Zy. Yu et al., EFFECTS OF HYPOXEMIA ON FETAL HEART-RATE, VARIABILITY AND CARDIAC-RHYTHM, Clinical and experimental pharmacology and physiology, 25(7-8), 1998, pp. 577-584
1. Experiments were carried out in 30 chronically catheterized foetal
sheep (128-144 days; term 150 days) and in seven of these foetuses bef
ore, during and after acute hypoxaemia. The extent to which changes in
sympathoadrenal activity and cardiac vagal activity affected the foet
al cardiac response to hypoxaemia was measured. Three measurements wer
e used: foetal heart rate (FHR), heart rate variability (HRV; measured
as the coefficient of variation in pulse interval) and power spectral
density (PSD; measured over the frequency ranges of 0.04-1.3 Hz). Car
diac vagal activity was blocked by atropine, beta-adrenoceptor activit
y was blocked by propranolol. 2. Under normoxaemic conditions, cardiac
vagal blockade caused a rise in mean arterial pressure (MAP; P<0.001)
, an increase in FHR (P<0.001), a decrease in HRV (P<0.001) and a decr
ease in PSD (P<0.001). beta-Adrenoceptor blockade caused a rise in MAP
(P<0.001), a fall in FHR (P<0.01), a decrease in HRV (P<0.001) but no
change in PSD. 3. During mild hypoxaemia (Po-2 = 12-14.5 mmHg) and mo
derate hypoxaemia (Po-2 = 10-11.9 mmHg), foetal MAP (P<0.001, P<0.001)
, HRV (P<0,01, P<0.001) and PSD in the frequency range 0.04-0.45 Hz in
creased (P<0.05-P<0.001). Foetal heart rate decreased when foetuses be
came moderately hypoxaemic (P<0.001). 4.After cardiac vagal blockade,
hypoxaemia was associated with an increase in FHR compared with non-bl
ocked hypoxaemic foetuses (P<0.01, P<0.001). The increase in HRV was a
bolished (P<0.001, P<0.001) as was the increase in PSD (P<0.01-P<0.001
). 5, After beta-adrenoceptor blockade, the bradycardia that occurred
during hypoxaemia was enhanced (P<0.01, P<0.05), the increase in HRV w
as not affected and neither was the increase in PSD. 6. As FHR and HRV
of normoxaemic foetal sheep were affected both by atropine and propra
nolol, it would seem that both cardiac vagal and sympathoadrenal activ
ity modulate the foetal heart under resting conditions. The lack of an
y effect of beta-adrenoceptor blockade on PSD under these conditions s
uggests that power spectral analysis (PSA) is not as sensitive as the
other two methods in detecting sympathetically mediated modulation of
the heart. 7. Because the hypoxaemia induced bradycardia and increase
in HRV and in PSD were abolished by atropine (P<0.01-P<0.001), it is c
oncluded that during hypoxaemia foetal HRV is mainly modulated by chan
ges in cardiac vagal tone. Propranolol had no effect on foetal HRV, al
though it reduced it under normoxaemic conditions; therefore, it is co
ncluded that cardiac sympathetic neural activity was not increased in
acute hypoxaemia uncomplicated by acidosis. However, there was strong
evidence of increased sympathoadrenal tone on the foetal heart in hypo
xaemia, that is, there was a rise in FHR in hypoxaemic atropinized foe
tuses and a greater fall in FHR in beta-adrenoceptor blocked hypoxaemi
c foetuses, Therefore, this increased sympathetic influence on the foe
tal heart during hypoxaemia must be predominantly the result of increa
sed adrenomedullary secretion of catecholamines. 8. Maintenance of foe
tal cardiac output depends on the chronotropic and ionotropic effects
of catecholamines. Therefore, this adrenomedullary influence on the fo
etal heart during hypoxaemia is important to offset the opposing effec
ts of increased cardiac vagal tone.